205 related articles for article (PubMed ID: 35282118)
1. Stereotactic Body Radiotherapy vs. Radiofrequency Ablation in the Treatment of Hepatocellular Carcinoma: A Meta-Analysis.
Pan YX; Fu YZ; Hu DD; Long Q; Wang JC; Xi M; Liu SL; Xu L; Liu MZ; Chen MS; Zhang YJ
Front Oncol; 2020; 10():1639. PubMed ID: 33194569
[No Abstract] [Full Text] [Related]
2. Combination radiofrequency ablation and vertebral cement augmentation for spinal metastatic tumors: A systematic review and meta-analysis of safety and treatment outcomes.
Chen AL; Sagoo NS; Vannabouathong C; Reddy Y; Deme S; Patibandla S; Passias PG; Vira S
N Am Spine Soc J; 2024 Mar; 17():100317. PubMed ID: 38510810
[TBL] [Abstract][Full Text] [Related]
3. Clinical Outcomes After Stereotactic Body Radiation Therapy for Nonspinal Bone Metastases: A Systematic Review and Meta-analysis.
Singh R; Valluri A; Lehrer EJ; Cao Y; Upadhyay R; Trifiletti DM; Lo SS; Redmond KJ; Sahgal A; Nguyen QN; Palmer JD
Int J Radiat Oncol Biol Phys; 2024 Jan; ():. PubMed ID: 38220068
[TBL] [Abstract][Full Text] [Related]
4. Triaging early-stage lung cancer patients into non-surgical pathways: who, when, and what?
Sroufe R; Kong FM
Transl Lung Cancer Res; 2015 Aug; 4(4):438-47. PubMed ID: 26380185
[TBL] [Abstract][Full Text] [Related]
5. Meta-Analysis of STereotactic body radiothERapy in non-spine BONE metastaseS (MASTER-BONES).
Moraes FY; Gouveia AG; Marta GN; da Silva MF; Hamamura AC; Tsakiridis T; Yan M; Viani GA
Int J Radiat Oncol Biol Phys; 2024 Jan; ():. PubMed ID: 38244875
[TBL] [Abstract][Full Text] [Related]
6. Radiomics in stereotactic body radiotherapy for non-small cell lung cancer: a systematic review and radiomic quality score study.
Cheung BMF
Radiat Oncol J; 2024 Mar; 42(1):4-16. PubMed ID: 38549380
[TBL] [Abstract][Full Text] [Related]
7. Combination of Local Ablative Techniques with Radiotherapy for Primary and Recurrent Lung Cancer: A Systematic Review.
Bonome P; Pezzulla D; Lancellotta V; Scrofani AR; Macchia G; Rodolfino E; Tagliaferri L; Kovács G; Deodato F; Iezzi R
Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136413
[TBL] [Abstract][Full Text] [Related]
8. Risk factors of local control in adrenal metastases treated by stereotactic body radiation therapy - a systematic review and meta-analysis.
Liao X; Kishi K; Du K; Komaki R; Mizoe J; Aikawa G; Zheng W; Pan C
Front Oncol; 2023; 13():1193574. PubMed ID: 38045003
[TBL] [Abstract][Full Text] [Related]
9. Patients Offer Radiofrequency Ablation Therapy for Early Breast Cancer as Local Therapy (PO-RAFAELO) Study under the Patient-proposed Health Services.
Takayama S; Kinoshita T; Shiino S; Jimbo K; Watanabe KI; Fujisawa T; Yamamoto N; Onishi T; Shien T; Ito M; Takahashi M; Futamura M; Aruga T; Kaneko K; Suto A
JMA J; 2023 Oct; 6(4):505-512. PubMed ID: 37941717
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous local tumor ablation vs. stereotactic body radiotherapy for early-stage non-small cell lung cancer: a systematic review and meta-analysis.
Chen D; Zhao M; Xiang X; Liang J
Chin Med J (Engl); 2022 Jul; 135(13):1517-24. PubMed ID: 35830244
[TBL] [Abstract][Full Text] [Related]
11. A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation-part 4: systematic review of evidence involving SBRT and ablation.
Park HS; Detterbeck FC; Madoff DC; Bade BC; Kumbasar U; Mase VJ; Li AX; Blasberg JD; Woodard GA; Brandt WS; Decker RH
J Thorac Dis; 2022 Jun; 14(6):2412-2436. PubMed ID: 35813762
[TBL] [Abstract][Full Text] [Related]
12. Radiofrequency ablation for stage Zhao Q; Wang J; Fu YL; Hu B
Thorac Cancer; 2023 Nov; 14(32):3181-3190. PubMed ID: 37740563
[TBL] [Abstract][Full Text] [Related]
13. Innovative Invasive Loco-Regional Techniques for the Treatment of Lung Cancer.
Claes E; Wener R; Neyrinck AP; Coppens A; Van Schil PE; Janssens A; Lapperre TS; Snoeckx A; Wen W; Voet H; Verleden SE; Hendriks JMH
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190172
[TBL] [Abstract][Full Text] [Related]
14. Imaging Follow-Up of Nonsurgical Therapies for Lung Cancer:
Murphy DJ; Mayoral M; Larici AR; Ginsberg MS; Cicchetti G; Fintelmann FJ; Marom EM; Truong MT; Gill RR
AJR Am J Roentgenol; 2023 Oct; 221(4):409-424. PubMed ID: 37095669
[TBL] [Abstract][Full Text] [Related]
15. Image-Guided Percutaneous and Transarterial Therapies for Primary and Metastatic Lung Cancer.
Mansur A; Garg T; Camacho JC; Habibollahi P; Edward Boas F; Khorshidi F; Buethe J; Nezami N
Technol Cancer Res Treat; 2023; 22():15330338231164193. PubMed ID: 36942407
[TBL] [Abstract][Full Text] [Related]
16. Issues and prospects of image-guided thermal ablation in the treatment of primary and metastatic lung tumors.
Wang M; Wei Z; Ye X
Thorac Cancer; 2023 Jan; 14(1):110-115. PubMed ID: 36480492
[TBL] [Abstract][Full Text] [Related]
17. Comparison of stereotactic body radiotherapy and radiofrequency ablation for early-stage non-small cell lung cancer: a systematic review and meta-analysis.
Zhang R; Kang J; Ren S; Xing L; Xu Y
Ann Transl Med; 2022 Jan; 10(2):104. PubMed ID: 35282118
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the Effectiveness of Radiofrequency Ablation With Stereotactic Body Radiation Therapy in Inoperable Stage I Non-Small Cell Lung Cancer: A Systemic Review and Pooled Analysis.
Bi N; Shedden K; Zheng X; Kong FS
Int J Radiat Oncol Biol Phys; 2016 Aug; 95(5):1378-1390. PubMed ID: 27479723
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic body radiation therapy and thermal ablation for treatment of NSCLC: A systematic literature review and meta-analysis.
Laeseke P; Ng C; Ferko N; Naghi A; Wright GWJ; Zhang Y; Laidlaw A; Kalsekar I; Laxmanan B; Ghosh SK; Zhou M; Szapary P; Pritchett M
Lung Cancer; 2023 Aug; 182():107259. PubMed ID: 37321074
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
